Phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary) ; Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors Burzynski Research Institute
- 14 Apr 2016 Results from this trial published in Child's Nervous System in December 2014, as per Burzynski Research Institute, Inc media release.
- 16 Apr 2015 Results of subgroup analysis in patients with non-diffuse intrinsic pontine glioma published in Journal of Cancer Therapy, according to a Burzynski Research Institute media release.
- 16 Apr 2015 Results published in the Media Release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History